Bio Korea patented test composite and its methods for TB bacteria.

Published: 2006-01-20 06:57:00

Updated: 2006-01-20 06:57:00

Bio Korea announced on Dec. 20, last year that the company completed the PCT international patent for the primer composite and process of the TB bacteria test

The new test targeted on the unique part of TB bacteria, other part than IS6110, to reduce false responses, which greatly helps for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK